RUNX1 and acute myeloid leukemia: As this is the only retroviral model to establish a t(8;21)-like AML without the addition of cooperating mutations, it is commonly used for in vivo modeling of RUNX1-RUNX1T1 driven disease, though the full-length construct remains the preferred model for in vitro experiments.